|
16
|
99
|
3ou1B |
Mdr769 hiv-1 protease complexed with rh/in hepta-peptide |
|
19
|
99
|
3ok9A |
Crystal structure of wild-type hiv-1 protease with new oxatricyclic designed inhibitor grl-0519a |
|
16
|
99
|
3oucA |
Mdr769 hiv-1 protease complexed with p2/nc hepta-peptide |
|
16
|
99
|
3oq7A |
Crystal structures of multidrug-resistant clinical isolate 769 hiv-1 protease variants |
|
16
|
99
|
3oubA |
Mdr769 hiv-1 protease complexed with nc/p1 hepta-peptide |
|
17
|
99
|
3otsA |
Mdr769 hiv-1 protease complexed with ma/ca hepta-peptide |
|
22
|
112
|
3ogqA |
Crystal structure of 6s-98s fiv protease with lopinavir bound |
|
49
|
157
|
3p1gA |
Crystal structure of the xenotropic murine leukemia virus-related virus (xmrv) rnase h domain |
|
16
|
99
|
3otyA |
Mdr769 hiv-1 protease complexed with rt/rh hepta-peptide |
|
17
|
99
|
3ou1A |
Mdr769 hiv-1 protease complexed with rh/in hepta-peptide |
|
16
|
99
|
3oxwA |
Crystal structure of hiv-1 i50v, a71v protease in complex with the protease inhibitor darunavir |
|
17
|
99
|
3oudA |
Mdr769 hiv-1 protease complexed with ca/p2 hepta-peptide |
|
31
|
112
|
3ogpA |
Crystal structure of 6s-98s fiv protease with darunavir bound |
|
78
|
219
|
3p05A |
X-ray structure of pentameric hiv-1 ca |
|
16
|
99
|
3ou3A |
Mdr769 hiv-1 protease complexed with pr/rt hepta-peptide |
|
16
|
99
|
3oxxA |
Crystal structure of hiv-1 i50v, a71v protease in complex with the protease inhibitor atazanavir |
|
16
|
99
|
3ouaA |
Mdr769 hiv-1 protease complexed with p1/p6 hepta-peptide |
|
17
|
99
|
3oxvA |
Crystal structure of hiv-1 i50v, a71 protease in complex with the protease inhibitor amprenavir. |
|
16
|
99
|
3ou4B |
Mdr769 hiv-1 protease complexed with tf/pr hepta-peptide |
|
15
|
99
|
3oy4A |
Crystal structure of hiv-1 l76v protease in complex with the protease inhibitor darunavir. |
|
17
|
99
|
3oqdA |
Crystal structures of multidrug-resistant clinical isolate 769 hiv-1 protease variants |
|
16
|
99
|
3ou4A |
Mdr769 hiv-1 protease complexed with tf/pr hepta-peptide |
|
50
|
145
|
3o4qA |
Crystal structure of the rous associated virus integrase catalytic domain a182t in citrate buffer ph 6.2 |
|
18
|
99
|
3o9gA |
Crystal structure of wild-type hiv-1 protease in complex with af53 |
|
19
|
99
|
3o9iA |
Crystal structure of wild-type hiv-1 protease in complex with af61 |
|
47
|
141
|
3o4nA |
Crystal structure of the rous associated virus integrase catalytic domain in mes buffer ph 6.0 |
|
18
|
99
|
3o9fA |
Crystal structure of wild-type hiv-1 protease in complex with kd27 |
|
18
|
99
|
3o9hA |
Crystal structure of wild-type hiv-1 protease in complex with kd26 |
|
18
|
99
|
3nu6A |
Crystal structure of hiv-1 protease mutant i54m with antiviral drug amprenavir |
|
18
|
99
|
3nuoA |
Crystal structure of hiv-1 protease mutant l90m with antiviral drug amprenavir |
|
41
|
203
|
3nxnA |
X-ray structure of ester chemical analogue 'covalent dimer' [ile50,o-ile50']hiv-1 protease complexed with kvs-1 inhibitor |
|
16
|
99
|
3nu9A |
Crystal structure of hiv-1 protease mutant i84v with antiviral drug amprenavir |
|
27
|
124
|
3nr6A |
Crystal structure of xenotropic murine leukemia virus-related virus (xmrv) protease |
|
56
|
153
|
3nfaA |
Structural basis for a new mechanism of inhibition of hiv integrase identified by fragment screening and structure based design |
|
16
|
99
|
3nwqA |
X-ray structure of ester chemical analogue [o-ile50,o-ile50']hiv-1 protease complexed with mvt-101 |
|
18
|
99
|
3nujA |
Crystal structure of hiv-1 protease mutant i54v with antiviral drug amprenavir |
|
56
|
153
|
3nf6A |
Structural basis for a new mechanism of inhibition of hiv integrase identified by fragment screening and structure based design |
|
18
|
99
|
3nu5A |
Crystal structure of hiv-1 protease mutant i50v with antiviral drug amprenavir |
|
29
|
95
|
3nnqA |
Crystal structure of the n-terminal domain of moloney murine leukemia virus integrase, northeast structural genomics consortium target or3 |
|
56
|
153
|
3nf7A |
Structural basis for a new mechanism of inhibition of hiv integrase identified by fragment screening and structure based design |
|
20
|
99
|
3nu4A |
Crystal structure of hiv-1 protease mutant v32i with antiviral drug amprenavir |
|
15
|
99
|
3nlsA |
Crystal structure of hiv-1 protease in complex with kni-10772 |
|
16
|
99
|
3nwxA |
X-ray structure of ester chemical analogue [o-ile50,o-ile50']hiv-1 protease complexed with kvs-1 inhibitor |
|
17
|
99
|
3nygA |
X-ray structure of ester chemical analogue [o-gly51,o-gly51']hiv-1 protease complexed with mvt-101 inhibitor |
|
18
|
99
|
3nu3A |
Wild type hiv-1 protease with antiviral drug amprenavir |
|
53
|
153
|
3nf9A |
Structural basis for a new mechanism of inhibition of hiv integrase identified by fragment screening and structure based design |
|
17
|
99
|
3ndtA |
Hiv-1 protease saquinavir:ritonavir 1:1 complex structure |
|
40
|
203
|
3n3iA |
Crystal structure of g48v/c95f tethered hiv-1 protease/saquinavir complex |
|
20
|
99
|
3ndwA |
Hiv-1 protease saquinavir:ritonavir 1:15 complex structure |
|
19
|
99
|
3nduA |
Hiv-1 protease saquinavir:ritonavir 1:5 complex structure |
